Table I.
Expression of different proteins in ovarian cancer and adjacent normal tissues.
| Protein | Group | Total number of cases (n) | Positive (case) | Negative (case) | Positive rate (%) |
|---|---|---|---|---|---|
| WWOX | Ovarian cancer group | 300 | 113 | 187 | 37.7 |
| Adjacent tissue group | 300 | 264 | 36 | 88.0 | |
| Elf5 | Ovarian cancer group | 300 | 108 | 192 | 36.0 |
| Adjacent tissue group | 300 | 263 | 37 | 87.7 | |
| Snail1 | Ovarian cancer group | 300 | 199 | 101 | 66.3 |
| Adjacent tissue group | 300 | 27 | 273 | 9.0 | |
| E-cadherin | Ovarian cancer group | 300 | 91 | 209 | 30.3 |
| Adjacent tissue group | 300 | 240 | 60 | 80.0 | |
| N-cadherin | Ovarian cancer group | 300 | 154 | 146 | 51.3 |
| Adjacent tissue group | 300 | 42 | 258 | 14.0 | |
| Vimentin | Ovarian cancer group | 300 | 196 | 104 | 65.3 |
| Adjacent tissue group | 300 | 24 | 276 | 8.0 |
WWOX, WW domain-containing oxidoreductase.